Transfusion-dependent AnemiaNCT04155021
Knowledge and Attitude in Perioperative Erythrocyte Transfusion in Medical Personnel in Siriraj Hospital
An observational study of Transfusion-dependent Anemia, run by Siriraj Hospital at 1 site in Thailand.
Trial summary
This study is designed to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Transfusion-dependent Anemia
- How many people
- 250 participants
- Where
- 1 siteThailand
- Study dates
- 15 Jan 2020to 15 May 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Post-graduated medical personnel in Siriraj Hospital who associated with erythrocyte transfusion practice.
Who may be able to join
- Post-graduated medical personnel in Siriraj Hospital
Who cannot join
- Post-graduated medical personnel in Siriraj Hospital who refuse to participate
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Knowledge and Attitude in Perioperative Erythrocyte Transfusion in Medical Personnel of the Department of Anesthesiology and Department of Orthopedic Surgery in Siriraj Hospital
This study is designed to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel.
Read the detailed description
Inappropriate erythrocyte transfusion is still have high incidence even lots of the transfusion guidelines and researches was launched. Unnecessary or delayed transfusion can cause morbidity and mortality. This study is descriptive research, questionnaire based survey conducted to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel in Siriraj Hospital.
- Conditions
- Transfusion-dependent Anemia
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital
We aim to explore the reason of high incidence of inappropriate transfusion by conduct the questionnaire, about knowledge and attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital. Knowledge part will measure followed by transfusion guideline of Hematology and Anesthesiology, Siriraj Hospital and attitude toward perioperative transfusion will collect and analyse
Measured: 10 minutes
Secondary outcomes (1)
Attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital
We aim to explore the reason of high incidence of inappropriate transfusion by conduct the questionnaire, about knowledge and attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital. Knowledge part will measure followed by transfusion guideline of Hematology and Anesthesiology, Siriraj Hospital and attitude toward perioperative transfusion will collect and analyse
Measured: 10 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2019
- Study start15 Jan 2020
- Primary completion15 Jan 2022
- Study completion15 May 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Transfusion-dependent AnemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 250 participants (actual)
Sponsor and investigators
- Lead sponsor
- Siriraj Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mingkwan Wongyingsinn, MD, Siriraj Hospital
- Investigators
- Mingkwan Wongyingsinn, Principal investigator, Siriraj Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04155021
- Sponsor's protocol ID
- SIRB421
- Status last verified
- May 2022
- First submitted
- 5 Nov 2019
- Last updated
- 19 May 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Knowledge and Attitude in Perioperative Erythrocyte Transfusion in Medical Personnel of the Department of Anesthesiology and Department of Orthopedic Surgery in Siriraj Hospital
- ClinicalTrials.gov ID
- NCT04155021
- Acronym / sponsor ID
- SIRB421
- Conditions
- Transfusion-dependent Anemia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 250 participants (actual)
- Lead sponsor
- Siriraj HospitalUniversity, hospital or other
- Study start
- 15 Jan 2020 (actual)
- Primary completion
- 15 Jan 2022 (actual)
- Study completion
- 15 May 2022 (actual)
- First posted
- 7 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is designed to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel.
Detailed description
Inappropriate erythrocyte transfusion is still have high incidence even lots of the transfusion guidelines and researches was launched. Unnecessary or delayed transfusion can cause morbidity and mortality. This study is descriptive research, questionnaire based survey conducted to explore the correlation between knowledge and attitude in perioperative erythrocyte transfusion in medical personnel in Siriraj Hospital.
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Post-graduated medical personnel in Siriraj Hospital who associated with erythrocyte transfusion practice.
Key inclusion criteria (1 listed)
- Post-graduated medical personnel in Siriraj Hospital
Key exclusion criteria (1 listed)
- Post-graduated medical personnel in Siriraj Hospital who refuse to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Knowledge in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital
Time frame: 10 minutes
We aim to explore the reason of high incidence of inappropriate transfusion by conduct the questionnaire, about knowledge and attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital. Knowledge part will measure followed by transfusion guideline of Hematology and Anesthesiology, Siriraj Hospital and attitude toward perioperative transfusion will collect and analyse
1 secondary outcome
Attitude in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital
Time frame: 10 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 May 2022.
Related trials for Transfusion-dependent Anemia
RecruitingPhase 3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndromes
Active, not recruiting
Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.
Transfusion-dependent Beta-Thalassemia
RecruitingPhase 1/2
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Bone Marrow Failure Syndromes, Aplastic Anemias
RecruitingObservational study
First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms
Myelodysplastic Neoplasms
RecruitingPhase 2
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mingkwan Wongyingsinn principal investigator
Siriraj Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Transfusion-dependent Anemia, run by Siriraj Hospital at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge in perioperative erythocyte transfusion in medical personnel in Siriraj Hospital (time frame: 10 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2022.